Directory › Eurofins BioPharma Product Testing

Eurofins BioPharma Product Testing — Dungarvan

Dungarvan, Ireland · Testing lab

This is a record of what regulators published, not a rating.

Site facts

Company
Eurofins BioPharma Product Testing
Name(s) in FDA data
Eurofins Biopharma Product Testing Ireland Limited
FEI number(s)
3002807550 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Dungarvan, Ireland
Records matched
6 FDA inspections
Most recent FDA inspection in dataset
20 Jun 2025 — NAI

Capabilities (from the company's website)

  • Analytical testing
    …and NAT Small molecules Supporting your facility Services that span risk identification, method development, sampling, analytical validation, and ongoing monitoring Disinfectant validation ensures…
  • Microbiology
    …agents are fit for purpose and that your facility is safe for production. A full suite of environmental monitoring services designed to be as rigorous, responsive, and reliable as your cleanroom demands.…

Taken from a company-level page; the company does not publish a separate page for this site, so tags may describe the wider organisation. Source: https://www.eurofins.com/en/biopharma-services/biopharma-product-testing/, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 20 Jun 2025
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Biologics. Project area(s): Blood and Blood Products; Human Cellular, Tissue, and Gene Therapies.

    Source: FDA Data Dashboard – Inspections (FEI 3002807550, inspection ID 1280309)

  2. 26 May 2023
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002807550, inspection ID 1270954)

  3. 17 Jan 2019
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002807550, inspection ID 1127573)

  4. 24 Feb 2017
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002807550, inspection ID 1008821)

  5. 29 Mar 2013
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002807550, inspection ID 826551)

  6. 30 Sep 2009
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002807550, inspection ID 618581)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.